Erschienen in:
01.09.2008 | Letter to the Editor
Leukocytapheresis for the treatment of refractory Henoch–Schönlein purpura resistant to both prednisolone and intravenous immunoglobulin therapy
verfasst von:
Eishin Oki, Koji Tsugawa, Koichi Suzuki, Etsuro Ito, Hiroshi Tanaka
Erschienen in:
Rheumatology International
|
Ausgabe 11/2008
Einloggen, um Zugang zu erhalten
Abstract
Henoch–Schönlein purpura (HSP) is a childhood disorder, which is the vasculitis of systemic small vessels of unknown etiology. We encountered the dramatic efficacy of leukocytapheresis in a Japanese girl with refractory HSP resistant to combined prednisolone plus intravenous immunoglobulin therapy administration.